ROYALTY PHARMA PLC- CL A (RPRX) Stock Analyst Ratings
NASDAQ:RPRX - Nasdaq - GB00BMVP7Y09 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 81% to RPRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 39.06. This target is 24.95% above the current price.
RPRX was analyzed by 15 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about RPRX.
In the previous month the buy percentage consensus was at a similar level.
RPRX was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-25 | Citigroup | Maintains | Buy -> Buy |
| 2024-08-14 | Goldman Sachs | Maintains | Buy -> Buy |
| 2024-07-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2024-06-03 | UBS | Downgrade | Buy -> Neutral |
| 2024-04-12 | B of A Securities | Maintains | Buy -> Buy |
| 2024-02-20 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-02-20 | Goldman Sachs | Maintains | Buy -> Buy |
| 2023-11-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-08-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2023-07-11 | Morgan Stanley | Reiterate | Overweight -> Overweight |
| 2023-05-10 | Morgan Stanley | Maintains | Overweight |
| 2023-04-10 | Morgan Stanley | Maintains | Overweight |
| 2023-02-16 | UBS | Maintains | Buy |
| 2022-12-06 | Morgan Stanley | Maintains | Overweight |
| 2022-11-09 | Morgan Stanley | Maintains | Overweight |
| 2022-10-18 | JP Morgan | Maintains | Overweight |
| 2022-08-08 | Morgan Stanley | Maintains | Overweight |
| 2022-07-14 | Tigress Financial | Maintains | Buy |
| 2022-06-14 | UBS | Initiate | Buy |
| 2022-05-13 | ScotiaBank | Initiate | Outperform |
| 2022-04-27 | Goldman Sachs | Initiate | Buy |
| 2022-04-14 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2021-10-29 | Citigroup | Upgrade | Neutral -> Buy |
| 2021-08-16 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-07-30 | Tigress Financial | Initiate | Buy |